MicroRNA-451 Exacerbates Lipotoxicity in Cardiac Myocytes and High-Fat Diet-Induced Cardiac Hypertrophy in Mice Through Suppression of the LKB1/AMPK Pathway

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Circulation Research

• Publication date

  2015-01-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.116.304707PMID 25362209
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA-144 Regulates Hepatic ATP Binding Cassette Transporter A1 and Plasma High-Density Lipoprotein After Activation of the Nuclear Receptor Farnesoid X Receptor

  2013cited by this paper
• A Glucagon-Like Peptide-1 Analog Reverses the Molecular Pathology and Cardiac Dysfunction of a Mouse Model of Obesity

  2013cited by this paper
• AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function.

  2013cited by this paper
• Mice Long-Term High-Fat Diet Feeding Recapitulates Human Cardiovascular Alterations: An Animal Model to Study the Early Phases of Diabetic Cardiomyopathy

  2013cited by this paper
• Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

  2013cited by this paper
• Micro-RNA-195 and -451 Regulate the LKB1/AMPK Signaling Axis by Targeting MO25

  2012cited by this paper
• Gadd45α: A Novel Diabetes-Associated Gene Potentially Linking Diabetic Cardiomyopathy and Baroreflex Dysfunction

  2012cited by this paper
• Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1.

  2012cited by this paper
• Lipid metabolism and toxicity in the heart.

  2012cited by this paper
• miR451 and AMPK Mutual Antagonism in Glioma Cell Migration and Proliferation: A Mathematical Model

  2011cited by this paper
• Deficiency in AMP-activated protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contractile dysfunction.

  2011cited by this paper
• MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy.

  2011cited by this paper
• Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage

  2011cited by this paper
• AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function.

  2011cited by this paper
• Intravenous Gene Therapy With PIM-1 Via a Cardiotropic Viral Vector Halts the Progression of Diabetic Cardiomyopathy Through Promotion of Prosurvival Signaling

  2011cited by this paper
• Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3zeta.

  2010cited by this paper
• Nongenetic method for purifying stem cell–derived cardiomyocytes

  2010cited by this paper
• MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism.

  2010cited by this paper
• A Novel miRNA Processing Pathway Independent of Dicer Requires Argonaute2 Catalytic Activity

  2010cited by this paper
• MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.

  2010cited by this paper
• Rescue of Cardiomyopathy in Peroxisome Proliferator-Activated Receptor-α Transgenic Mice by Deletion of Lipoprotein Lipase Identifies Sources of Cardiac Lipids and Peroxisome Proliferator-Activated Receptor-α Activators

  2010cited by this paper
• MicroRNA-27a Regulates Beta Cardiac Myosin Heavy Chain Gene Expression by Targeting Thyroid Hormone Receptor β1 in Neonatal Rat Ventricular Myocytes

  2010cited by this paper
• Lipotoxicity in the heart.

  2010cited by this paper
• MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo

  2010cited by this paper
• Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death.

  2010cited by this paper
• The protective role of ROS in autoimmune disease.

  2009cited by this paper
• microRNA-451 Regulates Macrophage Migration Inhibitory Factor Production and Proliferation of Gastrointestinal Cancer Cells

  2009cited by this paper
• Adaptive and Maladptive Effects of SMAD3 Signaling in the Adult Heart After Hemodynamic Pressure Overloading

  2009cited by this paper
• Cardiac-specific Deletion of LKB1 Leads to Hypertrophy and Dysfunction

  2009cited by this paper
• Suppression of Phosphoinositide 3-Kinase Prevents Cardiac Aging in Mice

  2009cited by this paper
• Nutrient Stress Activates Inflammation and Reduces Glucose Metabolism by Suppressing AMP-Activated Protein Kinase in the Heart

  2009cited by this paper
• Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart

  2008cited by this paper
• Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population.

  2008cited by this paper
• Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet.

  2008cited by this paper
• Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats

  2008cited by this paper
• AMPK phosphorylation of raptor mediates a metabolic checkpoint.

  2008cited by this paper
• Cardiac cell death in early diabetes and its modulation by dietary fatty acids.

  2006cited by this paper
• A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor α

  2005cited by this paper
• Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux Published, JLR Papers in Press, August 1, 2005. DOI 10.1194/jlr.M500187-JLR200

  2005cited by this paper
• LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1

  2004cited by this paper
• Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart

  2004cited by this paper
• What is known

  2003cited by this paper
• Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging

  2003cited by this paper
• MO25α/β interact with STRADα/β enhancing their ability to bind, activate and localize LKB1 in the cytoplasm

  2003cited by this paper
• MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm.

  2003cited by this paper
• Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy.

  2003cited by this paper
• Method for Quantitative Determination of Cerebroside in “Plant Ceramide” Foodstuffs by High Performance Liquid Chromatography with Evaporative Light Scattering Detection

  2002cited by this paper
• Palmitate-induced apoptosis in neonatal cardiomyocytes is not dependent on the generation of ROS.

  2002cited by this paper
• Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4*

  2001cited by this paper
• The monoclonal antibody specific for the 4‐hydroxy‐2‐nonenal histidine adduct

  1995cited by this paper
• Cellular toxicity of fecal water depends on diet.

  1987cited by this paper
• Br Ief Definitive Repor T

  year unknowncited by this paper

• Energy-sensing molecule RORγ regulates cholesterol metabolism and immune signaling in diabetic kidney disease and aging.

  2026cites this paper
• FGF9 alleviates diabetic cardiomyopathy by activating Nrf2 via SQSTM1/p62-Keap1 in mice

  2025cites this paper
• Impact of Olive Oil Components on the Expression of Genes Related to Type 2 Diabetes Mellitus

  2025cites this paper
• MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathy

  2025cites this paper
• Role and Significance of MicroRNAs in the Relationship Between Obesity and Cancer

  2025cites this paper
• Finerenone ameliorates high-fat-induced myocardial lipotoxicity by suppressing ferroptosis through augmenting the system Xc-/GSH synthesis pathway.

  2025cites this paper
• Mechanistic insight into the role of cardiac-enriched microRNAs in diabetic heart injury.

  2025cites this paper
• Obesity and Heart Failure: Mechanistic Insights and the Regulatory Role of MicroRNAs

  2025cites this paper
• Mammalian conserved Drosophila miR-6 regulation of LRP1 in the heart protects against normal cardiac aging.

  2025cites this paper
• Start small, think big: MicroRNAs in diabetes mellitus and relevant cardiorenal-liver metabolic health spectrum.

  2025cites this paper
• miR-451 Is a Driver of Lipotoxic Injury in Patients with Diabetic Cardiomyopathy

  2025influential citation
• Remodeling of non-coding RNA regulatory networks: Decoding the pathological mechanisms and new therapeutic paradigms of cardiovascular diseases.

  2025cites this paper
• Berberine partially ameliorates cardiolipotoxicity in diabetic cardiomyopathy by modulating SIRT3‐mediated lipophagy to remodel lipid droplets homeostasis

  2025cites this paper
• Lipotoxicity as a therapeutic target in the type 2 diabetic heart.

  2025cites this paper
• Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy

  2025cites this paper
• MiR-451a attenuates hepatic steatosis and hepatitis C virus replication by targeting glycerol kinase

  2025cites this paper
• Molecular Basis of Cardiomyopathies in Type 2 Diabetes

  2024cites this paper
• MicroRNAs as Epigenetic Regulators of Obesity.

  2024cites this paper
• Roles of non-coding RNA in diabetic cardiomyopathy

  2024cites this paper
• Therapeutic strategies targeting mechanisms of macrophages in diabetic heart disease

  2024cites this paper
• Epigenetics in diabetic cardiomyopathy

  2024cites this paper
• MicroRNA-451a downregulation in liraglutide-treated individuals with diabetes: A potential cardiovascular protective mechanism

  2024cites this paper
• Taurine alleviated hepatic steatosis in oleic acid-treated-HepG2 cells and rats fed a high-fat diet

  2023influential citation
• MOTS-c repairs myocardial damage by inhibiting the CCN1/ERK1/2/EGR1 pathway in diabetic rats

  2023cites this paper
• Effects of non-coding RNAs and RNA-binding proteins on mitochondrial dysfunction in diabetic cardiomyopathy

  2023cites this paper
• Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation

  2023cites this paper
• Fibroblast growth factor 18 alleviates stress-induced pathological cardiac hypertrophy in male mice

  2023cites this paper
• Asiatic acid: a review on its polypharmacological properties and therapeutic potential against various Maladies

  2023cites this paper
• Interplay Between TGF-β Signaling and MicroRNA in Diabetic Cardiomyopathy

  2023cites this paper
• Honokiol ameliorates angiotensin II‐induced cardiac hypertrophy by promoting dissociation of the Nur77–LKB1 complex and activating the AMPK pathway

  2023cites this paper
• Integrated small RNA, mRNA and protein omics reveal a miRNA network orchestrating metabolic maturation of the developing human heart

  2023cites this paper
• Therapeutic strategies targeting AMPK-dependent autophagy in cancer cells.

  2023cites this paper
• Quercetin and Its Derivative Counteract Palmitate-Dependent Lipotoxicity by Inhibiting Oxidative Stress and Inflammation in Cardiomyocytes

  2023cites this paper
• MicroRNA-32-3p facilitates cerebral ischemia/reperfusion injury through inhibiting Cab39/AMPK.

  2023cites this paper
• LncRNA ZNF593-AS alleviates diabetic cardiomyopathy via suppressing IRF3 signaling pathway

  2023cites this paper
• Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice

  2023cites this paper
• Targeting epigenetics in diabetic cardiomyopathy: Therapeutic potential of flavonoids.

  2022cites this paper
• Astragalus polysaccharides alleviates cardiac hypertrophy in diabetic cardiomyopathy via inhibiting the BMP10-mediated signaling pathway.

  2022cites this paper
• Identification of the hub genes related to adipose tissue metabolism of bovine

  2022cites this paper
• New insights into activation and function of the AMPK

  2022cites this paper
• Natural AMPK Activators in Cardiovascular Disease Prevention

  2022cites this paper
• Sirtuin 3: Emerging therapeutic target for cardiovascular diseases.

  2022cites this paper
• Effects of acupuncture treatment on microRNAs expression in ovarian tissues from Tripterygium glycoside-induced diminished ovarian reserve rats

  2022cites this paper
• Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease

  2022cites this paper
• Modelling Diabetic Cardiomyopathy: Using Human Stem Cell-Derived Cardiomyocytes to Complement Animal Models

  2022cites this paper
• Pyrroloquinoline Quinone inhibits PCSK9, augments LDLR recycling and enhances the effect of atorvastatin

  2022cites this paper
• Diet-induced obesity impairs spermatogenesis: the critical role of NLRP3 in Sertoli cells

  2022cites this paper
• LKB1: An emerging therapeutic target for cardiovascular diseases.

  2022cites this paper
• The Protective Effects of Neurotrophins and MicroRNA in Diabetic Retinopathy, Nephropathy and Heart Failure via Regulating Endothelial Function

  2022cites this paper
• Polyphenols target miRNAs as a therapeutic strategy for diabetic complications

  2022cites this paper
• Circular RNA circ_0001006 aggravates cardiac hypertrophy via miR-214-3p/PAK6 axis

  2022cites this paper
• Fibroblast growth factor 7 alleviates myocardial infarction by improving oxidative stress via PI3Kα/AKT-mediated regulation of Nrf2 and HXK2

  2022cites this paper
• MicroRNA-mediated control of myocardial infarction in diabetes.

  2022cites this paper
• MicroRNAs in Obesity-Associated Disorders: The Role of Exercise Training

  2022cites this paper
• MicroRNAs in cardiovascular diseases

  2022influential citation
• lncRNA NBR2 attenuates angiotensin II-induced myocardial hypertrophy through repressing ER stress via activating LKB1/AMPK/Sirt1 pathway

  2022cites this paper
• Eucalyptol relieves imidacloprid-induced autophagy through the miR-451/Cab39/AMPK axis in Ctenopharyngodon idellus kidney cells†.

  2022cites this paper
• miR‐141‐3p regulates saturated fatty acid‐induced cardiomyocyte apoptosis through Notch1/PTEN/AKT pathway via targeting PSEN1

  2021cites this paper
• MicroRNA targets and biomarker validation for diabetes-associated cardiac fibrosis.

  2021cites this paper
• Regulating Polyamine Metabolism by miRNAs in Diabetic Cardiomyopathy

  2021cites this paper
• Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes

  2021cites this paper
• Saturated fatty acid-induced cardiomyopathy with diastolic dysfunction can be ameliorated by changing the quality of fatty acids to monounsaturated fatty acid

  2021cites this paper
• The Expression of miR-365 in Serum of Hypertension Patients with Left Ventricular Hypertrophy Was Up-Regulated, Which Was Positively Correlated with Left Ventricular Mass Index

  2021cites this paper
• Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.

  2021cites this paper
• Roles of MicroRNAs in Glucose and Lipid Metabolism in the Heart

  2021cites this paper
• Interactions between the ERK1/2 signaling pathway and PCAF play a key role in PE-induced cardiomyocyte hypertrophy

  2021cites this paper
• miR-337-5p promotes the development of cardiac hypertrophy by targeting Ubiquilin-1 (UBQLN1)

  2021cites this paper
• Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy

  2021cites this paper
• Vitamin C supplementation reduces expression of circulating miR-451a in subjects with poorly controlled type 2 diabetes mellitus and high oxidative stress

  2021cites this paper
• Concurrent diabetes and heart failure: interplay and novel therapeutic approaches.

  2021cites this paper
• PGPM_A_319945 905..913

  2021cites this paper
• Effects of obesity on the cardiac proteome

  2021cites this paper
• Systemic Inhibition of miR-451 Increases Fibrotic Signaling and Diminishes Autophagic Response to Exacerbate Renal Damage in Tallyho/Jng Mice.

  2020cites this paper
• Supplementation of pyrroloquinoline quinone with atorvastatin augments mitochondrial biogenesis and attenuates low grade inflammation in obese rats.

  2020cites this paper
• Lionheart LincRNA alleviates cardiac systolic dysfunction under pressure overload

  2020cites this paper
• MicroRNA-27 attenuates pressure overload-Induced cardiac hypertrophy and dysfunction by targeting galectin-3.

  2020cites this paper
• Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure

  2020cites this paper
• Role of Non-coding RNA in Diabetic Cardiomyopathy.

  2020cites this paper
• microRNA Expression Profiles in Myocardium of High-Fat Diet-Induced Obesity Rat

  2020cites this paper
• miR‐155‐5p inhibition rejuvenates aged mesenchymal stem cells and enhances cardioprotection following infarction

  2020cites this paper
• The Long Noncoding RNA Hotair Regulates Oxidative Stress and Cardiac Myocyte Apoptosis during Ischemia-Reperfusion Injury

  2020cites this paper
• Blood levels of microRNAs associated with ischemic heart disease differ between Austrians and Japanese: a pilot study

  2020cites this paper
• Empagliflozin Ameliorates Obesity-Related Cardiac Dysfunction by Regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet–Induced Obese Mice

  2020cites this paper
• The Expression of microRNA in Adult Rat Heart with Isoproterenol-Induced Cardiac Hypertrophy

  2020cites this paper
• Serum microRNA-1 and microRNA- 133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes

  2020cites this paper
• Modulation of Fatty Acid-Related Genes in the Response of H9c2 Cardiac Cells to Palmitate and n-3 Polyunsaturated Fatty Acids

  2020cites this paper
• miR-410-5p promotes the development of diabetic cardiomyopathy by suppressing PIM1-induced anti-apoptosis.

  2020cites this paper
• Subcellular microRNAs in diabetic cardiomyopathy

  2020cites this paper
• Serum microRNA-1 and microRNA- 133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes

  2020cites this paper
• Cardiosphere-derived exosomal microRNAs for myocardial repair in pediatric dilated cardiomyopathy

  2020cites this paper
• Serum microRNA-1 and microRNA- 133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes

  2020cites this paper
• Homeobox A4 suppresses vascular remodeling by repressing YAP/TEAD transcriptional activity

  2020cites this paper
• Sirt6-Mediated Endothelial-to-Mesenchymal Transition Contributes Toward Diabetic Cardiomyopathy via the Notch1 Signaling Pathway

  2020cites this paper
• Deletion of miRNA-22 Induces Cardiac Hypertrophy in Females but Attenuates Obesogenic Diet-Mediated Metabolic Disorders.

  2020cites this paper
• Serum microRNA-1 and microRNA- 133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes

  2020cites this paper
• Serum microRNA-1 and microRNA- 133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes

  2020cites this paper
• Bone marrow mesenchymal stem cells inhibit cardiac hypertrophy by enhancing FoxO1 transcription

  2020cites this paper
• Serum microRNA-1 and microRNA- 133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes

  2020cites this paper
• Lionheart LincRNA alleviates cardiac systolic dysfunction under pressure overload

  2020cites this paper
• DMSO_A_287287 4801..4808

  2020cites this paper